Ganesh A. Thakur - Concepedia

Author

Ganesh A. Thakur

Also Known As

G A Thakur, G Thakur, G. A. Thakur, G. Thakur, G.A. Thakur, Gagan Thakur, Gajendra Singh Thakur, Ganesh A Thakur, Ganesh A. Thakur, Ganesh Anant Thakur

187

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Northeastern University Indiana University Bloomington University of Aberdeen Dalhousie University University of Saskatchewan

About

Ganesh A. Thakur is an author at Northeastern University specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	35	1.4K
2	Natural Sciences	12	13	470
3	Social Sciences	11	11	221
4	Health Sciences	8	8	407
5	Engineering	7	7	271

Ganesh A. Thakur

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats Kelly S. Sink, Peter McLaughlin, Jodi Wood, Neuropsychopharmacology Cannabis UseInduce SignsPsychoactive DrugPsychiatryFunctional Selectivity	2007	155
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence Richard A. Slivicki, Zhili Xu, Pushkar M. Kulkarni, Biological Psychiatry InflammationMolecular PharmacologyPain ResearchCannabis UsePositive Allosteric Modulation	2017	136
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats Elizabeth J. Rahn, A. M. Zvonok, Ganesh A. Thakur, Journal of Pharmacology and Experimental Therapeutics	2008	113
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, ACS Chemical Neuroscience	2017	106
Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance Jiayi Pan, Lívia P. Mendes, Momei Yao, European Journal of Pharmaceutics and Biopharmaceutics NanomedicineNanotherapeuticsEngineeringPolymer-drug ConjugateMedicine	2019	101
Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation Ying Pei, Richard W. Mercier, Jenine K. Anday, Chemistry & Biology Cannabis UseBiochemistryG Protein-coupled ReceptorMedicineFunctional Selectivity	2008	100
Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels Jenny L. Wilkerson, Katherine R. Gentry, Ellen C. Dengler, Pain	2012	99
(-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor Robert P. Picone, Atmaram D. Khanolkar, Wei Xu, Molecular Pharmacology	2005	98
A Novel Example of Metal-Mediated Aromatic Thiolation in a Ruthenium Complex. Crystal Structure of Ru<sup>II</sup>(SC<sub>6</sub>H<sub>4</sub>NNC<sub>6</sub>H<sub>4</sub>N)<sub>2</sub> B.K. Santra, Ganesh A. Thakur, Prasanta Ghosh, Inorganic Chemistry Inorganic CompoundInorganic ChemistryCrystal StructureEngineeringHeterocyclic	1996	97
The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB<sub>2</sub> Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy Liting Deng, Josée Guindon, Kiran Vemuri, Molecular Pain	2012	97

Page 1